MedAvail Holdings, Inc.
MDVLDelisted Mar 21, 2024- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0001402479
MedAvail Holdings, Inc. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 6, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $6.16M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in MedAvail Holdings, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
MDVL is no longer listed, so this page shows Q4 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 21
- +2 vs. Q3 2023
- Shares held
- 1.37M
- −22.9K (−1.6%) vs. Q3 2023
- Total value
- $6.16M
- −$1.92M (−23.7%) vs. Q3 2023
- New holders
- 3
- 1 more added
- Sold out
- 1
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDVL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 21 | $6.16M |
| Q3 2023 | 19 | $8.08M |
| Q2 2023 | 27 | $16.5M |
| Q1 2023 | 27 | $19.5M |
| Q4 2022 | 32 | $20.6M |
| Q3 2022 | 33 | $53.9M |
| Q2 2022 | 40 | $92.8M |
| Q1 2022 | 50 | $30.0M |
| Q4 2021 | 53 | $36.8M |
| Q3 2021 | 49 | $78.5M |
| Q2 2021 | 45 | $348.1M |
| Q1 2021 | 34 | $372.4M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding MedAvail Holdings, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Redmile Group, LLC | 692,082 | $3.05M | 0.11% | 00.0% | Unchanged |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 300,588 | $1.35M | 2.63% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 117,897 | $529.4K | 0.38% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 87,618 | $393.4K | 0.00% | −28,682−24.7% | Reduced |
| Pura Vida Investments, LLC | 58,070 | $327.8K | 0.36% | 00.0% | Unchanged |
| Cigna Investments Inc | 47,789 | $211.0K | 0.04% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 20,000 | $89.8K | 0.00% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 16,732 | $75.1K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 14,031 | $63.0K | 0.00% | −6,990−33.3% | Reduced |
| HRT Financial LP | 10,618 | $46.0K | 0.00% | +10,618 | New |
| Tower Research Capital LLC (TRC) | 2,050 | $9.20K | 0.00% | +2,050 | New |
| BlackRock Inc. | 1,643 | $7.38K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 430 | $1.93K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 263 | $1.18K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 185 | $816 | 0.00% | +184+18,400.0% | Added |
| FMR LLC | 121 | $534 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 98 | $440 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 54 | $242 | 0.00% | −6−10.0% | Reduced |
| Bank of America Corp | 13 | $58 | 0.00% | +13 | New |
| Global Retirement Partners, LLC | 8 | $26 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 9 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 0 | $0 | 0.00% | −133−100.0% | Sold out |